Free Trial

CytoDyn (CYDY) News Today

CytoDyn logo
$0.12 0.00 (0.00%)
(As of 11/20/2024 ET)
CytoDyn Inc. stock logo
CytoDyn Inc. (OTCMKTS:CYDY) Sees Large Growth in Short Interest
CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) was the recipient of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 16,577,600 shares, a growth of 25.8% from the October 15th total of 13,179,400 shares. Based on an average trading volume of 6,265,900 shares, the days-to-cover ratio is presently 2.6 days.
CytoDyn Inc. stock logo
CytoDyn (OTCMKTS:CYDY) Shares Down 4% - Should You Sell?
CytoDyn (OTCMKTS:CYDY) Stock Price Down 4% - What's Next?
September 2024 Letter to Shareholders
CytoDyn Inc. stock logo
CytoDyn Inc. (OTCMKTS:CYDY) Sees Significant Growth in Short Interest
CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) was the recipient of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 10,797,300 shares, a growth of 25.3% from the July 31st total of 8,617,700 shares. Based on an average daily volume of 6,688,300 shares, the days-to-cover ratio is currently 1.6 days.
CytoDyn to Host Webcast to Provide Company Update
May 2024 Letter to Shareholders
CytoDyn Inc. stock logo
CytoDyn Inc. (OTCMKTS:CYDY) Sees Large Decline in Short Interest
CytoDyn Inc. (OTCMKTS:CYDY - Get Free Report) was the recipient of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 4,724,300 shares, a drop of 25.2% from the January 31st total of 6,311,900 shares. Based on an average daily trading volume, of 5,725,000 shares, the short-interest ratio is currently 0.8 days.
CytoDyn Says FDA Lifts Hold On Leronlimab
CytoDyn Announces FDA Has Lifted Clinical Hold
CytoDyn Inc CYDY
Investors file another lawsuit against CytoDyn
CytoDyn Announces Webcast to Provide Company Update
CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO
CytoDyn (OTC: CYDY)
CytoDyn President Cyrus Arman takes medical leave
CytoDyn to Hold Webcast to Provide a Company Update
CytoDyn: There Seems To Be No Redemption
Get CytoDyn News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

CYDY Media Mentions By Week

CYDY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYDY
News Sentiment

1.93

0.47

Average
Medical
News Sentiment

CYDY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYDY Articles
This Week

1

0

CYDY Articles
Average Week

Get CytoDyn News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYDY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:CYDY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners